Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 229
-6
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

A Prescription for Health and Fitness Based on Your Genes

Exercise has many health benefits. Yet, most people stop their exercise programs after they start them...

Mathematical model to reduce maternal and infant mortality in Southeast Asia

Maternal and child mortality in Southeast Asian countries is still very high, especially in poor and rural...

T Cell Vaccines as an Immunotherapy for Type 1 Diabetes

Type 1 Diabetes develops when CD4+ T cells aren't taught to differentiate between self-antigens and foreign...

Backer Badge Funded